Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.388
-0.012 (-2.98%)
At close: Oct 31, 2024, 4:00 PM
0.393
+0.005 (1.29%)
After-hours: Oct 31, 2024, 6:25 PM EDT

Company Description

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.

It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation.

The company was founded in 1984 and is based in San Diego, California.

Aethlon Medical, Inc.
Aethlon Medical logo
Country United States
Founded 1984
Industry Medical Devices
Sector Healthcare
Employees 14
CEO James Frakes

Contact Details

Address:
11555 Sorrento Valley Road, Suite 203
San Diego, California 92121
United States
Phone 619 941 0360
Website aethlonmedical.com

Stock Details

Ticker Symbol AEMD
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0000882291
CUSIP Number 00808Y307
ISIN Number US00808Y4061
Employer ID 13-3632859
SIC Code 3841

Key Executives

Name Position
James B. Frakes M.B.A. Chief Executive Officer, Chief Financial Officer, Secretary and Director
Guy F. Cipriani BS (Eng.), MBA Senior Vice President and Chief Operating Officer
Dr. Steven P. LaRosa M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Oct 3, 2024 8-K Current Report
Oct 2, 2024 8-K Current Report
Sep 19, 2024 8-K Current Report
Aug 15, 2024 ARS Filing
Aug 15, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Aug 15, 2024 DEF 14A Other definitive proxy statements
Aug 15, 2024 10-K/A [Amend] Annual report
Aug 14, 2024 10-Q Quarterly Report
Aug 14, 2024 8-K Current Report
Aug 12, 2024 8-K Current Report